-
Spinal CT has high potential for dose reduction of 50% or more for the majority of clinical applications.
-
Options and limitations of dose reduction are highly dependent on the clinical indications and application-specific techniques can further increase the achievable dose reduction.
-
Additional dose reduction can be expected from the clinical transition of artificial intelligence and photon counting CT in the upcoming years.
Introduction
Material and Methods
Search Strategy
Inclusion Criteria
Exclusion Criteria
Extraction of Data
Results
Study Selection
Study Characteristics
Patients
Scanned Spine Region
CT System, Acquisition and Reconstruction Parameters
Dose Reporting and Dose Reduction Calculation
Author | Year | Subjects (n) | Scanned region | Comparison | CT System | Acquisition parameters | Reconstruction (name, level) | Dose reduction | CTDIvol [mGy] | DLP [mGy*cm] | E [mSv] |
---|---|---|---|---|---|---|---|---|---|---|---|
Heggie [51] | 2005 | 205 75SD, MSCT 74LD, MSCT 56CD,SSCT | Lumbar | SDMSCT vs LDMSCT vs CDSSCT | SSCT (Siemens Somatom Plus 4) 16-MSCT (Siemens Sensation 16) | 120 kVp, 360 mAs SD,MSCT 120 kVp, 300 mAs LD,MSCT 140 kVp SSCT | NA | 20% | NA | 560.0SD 455.0LD 455.0CD | 6.1LD |
Mulkens [67] | 2007 | 191 51SD 140LD | Cervical | SD vs LD 6‑MDCT vs. 16-MDCT | 6‑MDCT (Siemens Emotion 6) 16-MDCT (Siemens Sensation 16) | 130 kV, 175 mAs SD,6 120 kV, 250 mAs SD,16 110–130 kV am LD,6 100–120 kV am LD,16 | NA | 61–71% | 23.2SD,6 19.2SD,16 15.3–23.2LD,6 12.5–19.48LD,16 | NA | 3.8SD 1.1–1.6LD |
Maxfield [35] | 2012 | 245 109SD 136LD | CAP BC | SDFBP vs. LDASIR | 64-MDCT (GE Lightspeed VCT) | NA | FBP ASIR | 20%CTDI,DLP | 17.1SD,CAP 14.2LD,CAP 61.7SD,BC 49.6LD,BC | 1165.0SD,CAP 1004.0LD,CAP 1327.0SD,BC 1067.0LD,BC | 19.8SD,CAP 17.1LD,CAP |
Geyer [36] | 2013 | 147 67SD 80LD | Cervical | SDFBP vs LDASIR | 64-MDCT (GE Lightspeed VCT XT)SD 64-MDCT (GE Discovery HD 750)LD | 120 kV, max. 300 mAsam | FBP ASIR (30%) | 55%CTDI 54%DLP | 21.4SD 9.6LD | 441.2SD 204.2LD | 2.4SD 1.1LD |
Ardley [61] | 2013 | 60 30rDA 30sDA 30SA | BC | rDA vs sDA vs SA | 128-MDCT (Philips Ingenuity) | 120 kVam | NA | 16% | 919.3sDA,c 813.1rDA,c | 1829.0rDA,t 1735.6sDA,t 1458.7SA,t | 3.4SA,t 4.0sDA,t 4.2rDA,t |
Mueck [33] | 2014 | 380 126SD,STD 254LD,SWIM | Cervical | SDSWIM vs LDSTD | 64-MDCT (GE Discovery HD 750) | 120 kV, 20–300 mAam | ASIR (30%) | 6% | 6.6SD 6.2LD | NA | 0.8SD 0.7LD |
Patro [37] | 2016 | 78 48SD,FBP 30LD,ASIR | Cervical | SDFBP vs LDASIR | 64-MDCT (GE Lightspeed) | 120 kV, 100–650 mAs SD 120 kV, 81–451 mAs LD | FBP ASIR (30%) | 36% | 16.8SD 10.7LD | 404.5SD 256.6LD | 2.4SD 1.5LD |
Mei [75] | 2017 | 24 12VF 12nVF | Thoracic Lumbar | SD vs LDS1 | 256-MDCT (Philips iCT) | 120 kV, 200–400 mA, 109 mAs SD 11–55 mAs LD | SIR | 50–90% | 7.5SD 0.8–3.8LD | NA | NA |
Lee [62] | 2017 | 263 126SD 137LD | Lumbar | SD vs LD BMI | 64-MDCT (Philips Ingenuity) | 120 kV, 200–300 mAsam SD 120 kV, 80–150 mAsam LD | HIR (iDose 4) | 47–69% | 11.9SD 6.2LD | 350.5SD 188.4LD | 4.9T, (3.6/4.7/5.7BMI) SD 2.1T, (1.1/2.0/3.0BMI) LD |
Weinrich [63] | 2018 | 80 40SD 40LD | Lumbar | SD vs LD | 256-MDCT (Philips Brilliance iCT) | 120 kV, 158 mAsr SD 140 kV, 70 mAsr LD | HIR (iDose 3SD, 4LD, 6LD) | 50%E | 11.4SD 6.9LD | 403.7SD 209.2LD | 6.2SD 3.2LD |
Lee [64] | 2018 | 144 76SD 68LD | Lumbar | SD vs LD | 320-MDCT (Toshiba Aquilion ONE dynamic volume CT) | 120 kVp, 200–300 mAsam SD 120 kVp, 80–150 mAsam LD | MBIR (AIDR) | 61%E | NA | NA | 5.4SD 2.1LD |
Anitha [73] | 2019 | 16 8VF 8nVF | Lumbar | SD vs LDS2 | 256-MDCT (Philips iCT) | 120 kV, 200–400 mA, 112 mAs SD 11–56 mAs LD | FBP | 50–90% | 7.7SD 0.8–3.8LD | NA | NA |
Sollmann [76] | 2019 | 35 23VF 12nVF | Whole spine | SD vs LDS1 | 64-MDCT (Philips Brilliance 64) | 120 kV, 143 mA, 180 mAsam SD 18–90 mAs LD | FBP | 50–90% | 11.7SD 1.2–5.9LD | NA | NA |
Tozakidou [65] | 2019 | 68 34SD 34LD | Cervical | SD vs LD | 128-MDCT (Siemens Somatom Definition AS+) | 120 kV, 195 mAs SD 120 kV, 105 mAs LD | IR (SAFIRE 3) | 51%E | 14.1SD 7.0LD | 319.7SD 156.4LD | 1.6SD 0.8LD |
Author | Year | Subjects (n) | Scanned region | Comparison | CT System | Acquisition parameters | Reconstruction (name, level) | Dose reduction | CTDIvol [mGy] | DLP [mGy*cm] | E [mSv] |
---|---|---|---|---|---|---|---|---|---|---|---|
Bohy [81] | 2007 | 60 8/37/15BMI1 | Lumbar | SD vs LDS1 | 4‑MDCT (Siemens Somatom Volume Zoom) | 140 kV, 200/300/400BMI1 mAs SD | NA | 35–80% | 40.0SD,a | NA | NA |
Yang [38] | 2014 | 164 50SD 58LD1 56LD2 | Lumbar | SD vs LD1 vs LD2 | 256-MDCT (Philips Brilliance iCT) | 120 kV, 300 mAsam SD 120 kV, 150 mAsam LD1 100 kV, 230 mAsam LD2 | FBPSD HIR (iDose 4)LD | 36%CTDI,LD1 47%DLP,LD1 60%CTDI, DLP,LD2 | 18.4SD 10.0LD1 7.3LD2 | 587.5SD 312.6LD1 233.2LD2 | 6.5SD 3.4LD1 2.6LD2 |
Yang [39] | 2016 | 113 55SD 58LD | Lumbar | SD vs LDHIR vs LDIMR | 256-MDCT (Philips Brilliance iCT) | 120 kV, 262 mAsam SD 120 kV, 129 mAsam LD | FBPSD HIR (iDose 4)LD MBIR (IMR 1)LD | 49% | 17.7SD 8.7LD | 580.5SD 283.4LD | 6.4SD 3.1LD |
Iyama [40] | 2017 | 34 | Lumbar | FBP vs IMR vs HIR | 256-MDCT (Philips Brilliance iCT) | 120 kV, 127 mAam | FBP MBIR (IMR 1) HIR (iDose 4) MRIm | NA | 15.6 | 227.8–743.2 | NA |
Lee [52] | 2017 | 260 143LD 117ULD | Lumbar | LD vs ULD BMI2 | 64-MDCT (Philips Ingenuity) | 120 kV, 150 mAs LD 120 kV, 30 mAs ULD | IR | 60–68% | 7.7LD 1.9ULD | 248.4LD 60.5ULD | 2.9T,LD 1.5/2.5/4.2BMI2,LD 0.7T,ULD 0.6/0.7/0.8BMI2,ULD |
Sollmann [77] | 2021 | 26 | Cervical Lumbosacral | SD vs LDS2 | 128-MDCT (Philips Ingenuity Core) | 120/140 kV, 322 mA, 95 (130–314) mAsam SD 6–98 mAsam LD | SIR | 50–97% | 13.8SD 0.4–6.9LD | 388.9SD | NA |
Author | Year | Subjects (n) | Scanned region | Comparison | CT System | Acquisition parameters | Reconstruction (name, level) | Dose reduction | CTDIvol [mGy] | DLP [mGy*cm] | E [mSv] |
---|---|---|---|---|---|---|---|---|---|---|---|
Abul-Kasim [70] | 2008 | 127SD 113LD 15CD | Thoracic Lumbar | SD vs LD vs CD | 16-MDCT (Siemens SOMATOM Sensation) | 120 kV, 165 mAs SD 120 kV, 25 mAs LD 120 kV, 60 mAs CD | NA | 95%E | 10.1SD 0.5LD 13.0C | 714.0SD 20.8LD 24.0C | 13.09SD 0.37LD 0.43C |
Sensakovic [66] | 2016 | 31 17SD 17LD | Thoracic Lumbar | SD vs LD | 128-MDCT (Philips Ingenuity Core) | NASD 100 kV, 25/40BMI mAs LD | NASD HIR (iDose 5)LD | 84–91%E | 8.9/13.0 BMI,pre,SD 14.1/11.9 BMI,po,SD 1.0/1.6 BMI,pre,LD 0.1/1.6 BMI,po,LD | 402.7/599.6BMI,pre,SD 553.5/429.5 BMI,po,SD 53.1/74.8 BMI,pre,LD 46.1/77.8 BMI,po,LD | 7.5/10.7 BMI,pre,SD 10.5/8.1 BMI,po,SD 1.0/1.4 BMI,pre,LD 0.9/1.3 BMI,po,LD |
Sollmann [74] | 2021 | 38 24pc 14nc | Whole spine | SD vs LDS | 128-MDCT (Philips Ingenuity Core) | 120–140 kVp, 288 mA, 148 mAsam SD | SIR | 50–95% | 12.6SD 0.6/1.3/3.2/6.3S,LD | NA | NA |
Author | Year | Subjects (n) | Scanned region | Intervention | Comparison | CT System | Acquisition parameters | Reconstruction (name, level) | Dose reduction | CTDIvol [mGy] | DLP [mGy*cm] | E [mSv] |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Shepherd [53] | 2011 | 100 50SD 50LD | Whole spine | PRI/PI | SD vs LD | 64-MDCT (GE Lightspeed VCT) | 120 kV, 549s/84p/84g/199pc mA SD 120 kV, 149s/30p/50g/50pc mA LD | NA | 86%DLP 90%E,c 81%E,l | NA | 1458.0SD 199LD | 9.7c,SD 17.5l,SD 1.1c,LD 3.3l,LD |
Schauberger [82] | 2012 | 80 | Lumbar | PRI/PI | Proceduralistpr Patient habitusdia | 16-MDCT (GE Lightspeed) | 120 kV, 100–440 mAam p 120 kV, 66/42/49/80 mApr g | NA | NA | 88/34/79/149pr | NA | NA |
Artner [34] | 2012 | 1923 1870SD 53LD | Lumbar | PRI/PI | SD vs LD | 16-MDCT (Siemens SOMATOM Emotion) | 130 kV, 120s/80p/50g mA SD 80 kV, 100s/80p/50g mA LD | NA | 85% | NA | NA | 1.49SD 0.22LD |
Artner [54] | 2012 | 100 50SD 50LD | Lumbar | PRI/PI | SD vs LD | 16-MDCT (Siemens SOMATOM Emotion) | 130 kV, 120s/80p/50g mA SD 80 kV, 100s/80p/50g mA LD | NA | 85%no | NA | 94.4SD 13.9LD | NASD 0.2LD |
Artner [55] | 2012 | 65 5SD,ctg 30LD,ctg 30flg | Sacral | PRI/PI | SD vs LD | 16-MDCT (Siemens SOMATOM Emotion) | 130 kV, 120s/80p/50g mA SD,ctg 80 kV, 50g mA LD,ctg 75–80 kV, 60 mAflg | NA | 94% | NA | 76.3SD,ctg 4.6LD,ctg 3.7fl | NA |
Paik [56] | 2014 | 247 124SD 123LD | Lumbar | PRI/PI | SDhcp vs LDscp | 16-MDCT (GE Brightspeed Elite) | 120 kV, 10s/50p/30g mA SD,hcp 120 kV, 10s/30p/30g mA SD,scp | NA | 85% | NA | 31.8SD 4.9LD | 0.5SD 0.09LD |
Shpilberg [71] | 2014 | 64 35SD 29LD | Whole spine | Biopsy | SD vs LD | 4‑MDCT (Siemens Volume Zoom) 8‑MDCT (GE Lightspeed Ultra) | 120 kV, > 200 mAs SD 80 kV, 40–60 mAs LD | NA | 76%CTDI 61%DLP | 285.2SD 69.5LD | 1541.0SD 601.5LD | NA |
Paik [57] | 2015 | 338 163SD 175LD | Cervical | PRI/PI | SDhcp vs LDscp | 16-MDCT (GE Brightspeed Elite) | 120 kV, 10s/50p/40g mA SD,hcp 120 kV, 10s/40p/40g mA LD,scp | NA | 80% | NA | 39.1SD 7.9LD | 0.5SD 0.1LD |
Amrhein [58] | 2016 | 80 40SD 40LD | Lumbar | PRI/PI | SD vs LD | 16-MDCT (GE Lightspeed) | 120 kV, 435(100–440)p mAam SD 120 kV, 68(50–100)p mA LD | NA | 78%DLP,t | 39.1p,SD 4.2p,LD | 432.1t,SD 313.1p,SD 94.2t,LD 27.9p,LD | NA |
Greffier [50] | 2017 | 602 162SD 440LD | Lumbar | PRI/PI Vertebral expansion Biopsy | SD vs LD | 64-MDCT (Siemens SOMATOM Definition AS+) | 120 kV, 275hm/60fm/60sm mAsr SD 100hm/80fm/80sm kV, 200hm/60fm/60sm mAsr LD | FBP | 58%hm 72%fm 72%sm | 18.3hm,SD 9.2fm,SD 5.1sm,SD 7.9hm,LD 2.6fm,LD 1.5sm,LD | NA | NA |
Elsholtz [68] | 2017 | 85 22SD 63LD | Lumbar | PRI/PI | SDhcp vs LDscp | 80-MDCT (Toshiba Aquilion PRIME) | 120 kV, 20p/20g mAs SD 100 kV, 10p/5g mAs LD | NA | 64% | NA | 8.9SD 3.2LD | 0.048SD 0.014LD |
Elsholtz [83] | 2017 | 79 183tp | Lumbar | PRI/PI | ULDBMI1 | 80-MDCT (Toshiba Aquilion PRIME) | 100 kV, 5 mAs | IR (AIDR) | NA | NA | 2.4/23/3.4BMI | 0.05/0.05/0.07BMI |
Elsholtz [59] | 2019 | 183 101SD 82LD | Cervical | PRI/PI | SDhcp vs LDscp | 64-MDCT (Siemens SOMATOM Definition)SD 80-MDCT (Toshiba Aquilion PRIME)LD | 100p/100g kVp, NAam,p/28g mAs SD 100p/80g kVp, 10p/5g mAs LD | FBPSD IR (AIDR)LD | 93% | NA | 22.0p,SD 1.7g,SD 24.3t,SD 0.8p,LD 1.0g,LD 1.8t,LD | 0.14t,SD 0.01t,LD |
Sollmann [32] | 2019 | 20 | Lumbosacral | PRI/PI | SD vs LDS1 | 128-MDCT (Philips Ingenuity Core) | 120 kV, 133 mA, 100 mAs p SD 120 kV, 1–50 mAs p SD | SIR (A) SIR (B) | 50–99% | 6.5SD 0.07–3.3LD | 26.0SD 0.3–13.0LD | NA |
Cordts [72] | 2020 | 64pro 44pro,SD 20pro,LD 13pat | Lumbosacral | LP | SD vs LD | 128-MDCT (Philips Ingenuity Core) 256-MDCT (Philips Brilliance iCT) | 120 kV, 133 mA, 100 mAs SD 120 kV, 40 mA, 30 mAs LD | HIR (iDose 4)SD MBIR (IMR)LD | 69%CTDI 83%DLP | 6.5SD 2.0LD | 58.0SD 10.0LD | NA |
Rosiak [69] | 2021 | 65pro 23pro,SD 42pro,LD 18pat | Lumbar | LP | SD vs LD | MDCT (Toshiba/Canon Aquilion One) | 120 kV, 100 mA SD 120 kV, 10 mA LD | NA | 89% | NA | 248.1SD 26.7LD | NA |
Paprottka [60] | 2022 | 204 102SD 102LD | Cervical Lumbosacral | PRI | SD vs LD | 128-MDCT (Philips Ingenuity Core) | 120 kV, 40 mA, 30 mAs SD 120 kV, 20–30 mA, 15–20 mAs LD | MBIR (IMR) | 34%p,DLP | 2.0p,SD 1.8p,LD | 10.2p,SD 6.8p,LD | NA |
Outcome Measures
Quantitative Measures
Qualitative Measures
Dose Reduction in Vertebral Fractures and Spinal Trauma
Vertebral Fracture Evaluation
Spinal Trauma
Dose Reduction in Degenerative Spine Disease
Dose Reduction in Perioperative Evaluation
Dose Reduction in Interventional Procedures
Periradicular Infiltrations and Other Pain Injections
Lumbar Punctures in SMA Patients
Other Interventions
Protocol Recommendations and Recommended Radiation Dose Levels
Tube voltage [kV] | Tube current time product range [mAs] | CTDIvol [mGy] | DLP [mGy*cm] | Reconstruction | Additional considerations | |
---|---|---|---|---|---|---|
Vertebral fractures and spinal trauma | 120 | 55–105 with ATCM | 6–11 | 204–254 | State of the art IR: ASIR, HIR or MBIR | Different arm positions available for cervical spine scans |
Degenerative spine disease | 120–140 | 30–150 with ATCM | 2–10 | 61–313 | State of the art IR: MBIR better than HIR | Use higher (effective) tube current time product for high BMI patients to maintain sufficient image quality |
Interventional procedures | 60–120 | 5–50 without ATCM | 2–10a | 2–94a | Use state-of-the-art IR over FBP if available | Optimize acquisition parameters for each phase of the procedure: Survey, planning, guide phase and postcontrast images Spot scanning better than helical scanning for planning images Sequential scanning better than helical scanning for guide phase images Reduce scanned area of interest as much as possible Set acquisition parameters according to patient habitus as scans are usually performed without ATCM |
Achievable dose (reference) | – | – | 17–25 | 362–531 | – | – |
Diagnostic reference level (reference) | – | – | 23–33 | 495–703 | – | – |